Lithuania vs Togo: Previously treated cases tested for RR-/MDR-TB
Lithuania
100.0%
in 2024
Togo
100.0%
in 2024
Lithuania rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Lithuania
- Togo
How they compare
Lithuania currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was Lithuania ahead.
Lithuania ranks 1st and Togo ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 12.6% | 87.4% | Lithuania |
| 2010s | 100.0% | 61.3% | 38.7% | Lithuania |
| 2020s | 100.0% | 92.2% | 7.8% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Lithuania or Togo?
- Lithuania, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Lithuania and Togo?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Togo?
- 17 years are reported by both, from 2007 to 2024.
- How do Lithuania and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Lithuania ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.